T

$TNXP

2 articles found
2 positive
0 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Tonix Pharmaceuticals

Tonix's TONMYA Shows Strong Pharmacokinetics Data as First New Fibromyalgia Treatment in 15 Years Gains Traction

Tonix Pharmaceuticals publishes peer-reviewed pharmacokinetic data for TONMYA, the first new fibromyalgia treatment in 15 years, showing rapid absorption and superior bioavailability.
TNXPFDA approvalclinical trial
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Tonix Pharma to Showcase Commercial Portfolio at BIO-Europe Spring 2026

Tonix Pharmaceuticals CEO to present commercial CNS portfolio at BIO-Europe Spring 2026, showcasing TONMYA® fibromyalgia launch success with 1,500+ prescriptions since November 2025.
TNXPclinical trialsbiotechnology